Global Veterinary Biologics Market Report 2026–2035: Key Forecasts and Growth Areas

January 28, 2026January 28, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the green-pharma solvent systems market from 2026–2035 with trusted insights from The Business Research Company

How much is the Veterinary Biologics Market valued at in 2026, and what valuation is forecast for 2030?

The veterinary biologics market size has demonstrated significant expansion in recent years. It is projected to expand from $13.61 billion in 2025 to $14.61 billion in 2026, at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historic period can be ascribed to the increasing prevalence of livestock diseases, a rise in the companion animal population, advancements in vaccine development, increased government funding for veterinary research, and the expansion of veterinary healthcare infrastructure.

The veterinary biologics market size is projected to undergo significant expansion over the next few years. It is expected to grow to $20.03 billion in 2030, achieving a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period stems from factors such as technological advancements in biologics, the increasing adoption of precision medicine in animals, a rise in global pet ownership, heightened awareness regarding zoonotic diseases, and the expanding veterinary diagnostics market. Prominent trends for the forecast period include an elevated focus on preventive animal healthcare, the growing uptake of rapid diagnostic solutions, the expansion of companion animal biologics, the integration of immunomodulators in veterinary treatments, and an increasing demand for livestock disease management solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12366&type=smp

What Drivers Are Influencing The Growth Of The Veterinary Biologics Market?

The future expansion of the veterinary biologics market is anticipated to be propelled by the rising trend of pet adoption. Pet adoption involves assuming care for a domesticated animal, often from a shelter or rescue organization, to provide it with a permanent and nurturing home. This increase in pet adoption stems from greater animal welfare awareness, as more individuals acknowledge the advantages of adopting rescued animals rather than purchasing pets. Veterinary biologics are instrumental in preventing the impact of various infectious diseases in pets, conferring immunity, managing zoonotic diseases, extending lifespan and improving quality of life, lowering veterinary healthcare costs, enhancing reproductive health, and offering more precise and customized treatment options. For instance, the American Pet Products Association, a US-based non-profit association, reported that in March 2025, ninety-four (94) million U.S. households owned at least one pet, an increase from eighty-two (82) million in 2023. Consequently, the rising rate of pet adoption is directly driving the growth of the veterinary biologics market.

What Segments Are Included Within The Veterinary Biologics Market?

The veterinary biologics market covered in this report is segmented –

1) By Product: Vaccines, Diagnostic Kits, Immunomodulators, Antiserums And Antibodies, Other Products

2) By Disease Type: Bluetongue, Foot And Mouth Disease, Brucellosis And Tuberculosis, Other Disease Types

3) By Distribution Channel: Veterinary Hospitals, Veterinary Clinics, Other Distribution Channels

4) By Application: Production Animal, Companion Animal

Subsegments:

1) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, DNA Vaccines

2) By Diagnostic Kits: Rapid Tests, Elisa Kits, Pcr-Based Diagnostic Kits

3) By Immunomodulators: Cytokines, Adjuvants, Immunostimulants

4) By Antiserums And Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Hyperimmune Serums

5) By Other Products: Probiotics, Prebiotics, Growth Factors, Toxoids

Which Innovation Trends Are Advancing Developments Within The Veterinary Biologics Market?

Leading companies in the veterinary biologics market are concentrating on developing innovative biologics, such as vaccines, to enhance animal welfare and prevent diseases. A vaccine functions by stimulating the immune system to identify and combat specific pathogens, thereby preventing infectious diseases through acquired immunity. For example, in August 2024, Merck Animal Health, a US-based global animal health company, launched an experimental autogenous vaccine designed to target avian metapneumovirus (aMPV) type B, after securing approval from the U.S. Department of Agriculture (USDA) for its manufacturing and sale. This vaccine, developed in collaboration with Cambridge Technologies, seeks to counter the severe respiratory issues in poultry caused by aMPV type B, which have resulted in substantial economic losses since late 2023. Manufactured at a modern facility in Minnesota, the vaccine incorporates an oil and water emulsion formulation intended to minimize tissue reactions post-vaccination, thereby addressing a crucial gap in the market where no commercially licensed vaccines were previously available.

Who Are The Primary Competitors In The Global Veterinary Biologics Market?

Major companies operating in the veterinary biologics market are Zoetis Inc., Merck Animal Health Inc., Boehringer Ingelheim Animal Health Inc., Elanco Animal Health, IDEXX Laboratories Inc., Virbac SA, Phibro Animal Health Corporation, Abaxis Inc., Bimeda Biologicals, Ceva Sante Animale S.A., Heska Corporation, Colorado Serum Company, Hester Biosciences Limited, INDICAL Bioscience GmbH, Intervet Inc., Hebei Veyong Animal Pharmaceutical Co. Ltd., Biomet Biologics LLC, CytoDyn Veterinary Medicine LLC, KM Biologics, HIPRA, Indian Immunologicals Ltd., Vetoquinol, Beijing SVA Vaccines Serums

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Veterinary Biologics Market?

North America was the largest region in the veterinary biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Veterinary Biologics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12366&type=smp

Browse Through More Reports Similar to the Global Veterinary Biologics Market 2026, By The Business Research Company

Veterinary Medicine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-medicine-global-market-report

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Veterinary Pharmaceuticals Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795